Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements


Original Research 


Role of peroxisome proliferator-activated receptor (PPAR)-α gene in Dyslipidemia.

Amir Rashid, Sadaf Jafar, Raja Khalid Yaqub.

Abstract
Objective: To identify the role of peroxisome proliferator-activated receptor ( PPAR)-α gene in Dyslipidemia.
Methodology: This experimental study was carried out at Center for research in experimental and applied medicine (CREAM) Department of Biochemistry and Molecular Biology, Army Medical College, Rawalpindi from December 20, 2016 to June 8, 2017. The study comprised of three groups; Group one included subjects who were healthy, group two was comprised of diabetic without dyslipidemia and group three included diabetics with dyslipidemia. Blood was collected and Primers specific to PPAR-α were designed on the basis of sequence available on website Primer BLAST. RNA was extracted with in first six hours of sample collection using Gene JET RNA purification kit (Thermo Scientific). For first strand cDNA synthesis Revert Aid Premium was utilized. Polymerase chain reaction was used for the isolation, amplification or detection of specific nucleotide sequences in genomic DNA. PCR products were visualized by Agarose gel electrophoresis. After Real time PCR, molecular analysis was quantified by comparative CT Method (ΔΔ Ct method). Positive value means down regulation and negative value means upregulation.
Results: Primers were optimized using conventional PCR. A single band at 224 base pair represented the amplification of PPAR-α gene. The PCR protocol was optimized for PPAR-α gene.
Conclusion: PPAR-α gene has important role in the homeostasis of lipid profile in the body. Upregulation or increased expression of this gene leads to reduction in lipid profile, while down regulation or suppression of this gene leads to deranged lipid levels.

Key words: Dyslipidemia, gene expression, metabolic process.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Amir Rashid
Articles by Sadaf Jafar
Articles by Raja Khalid Yaqub
on Google
on Google Scholar
Article Statistics
 Viewed: 1038
Downloaded: 1


How to Cite this Article
Pubmed Style

Rashid A, Jafar S, Yaqub RK. Role of peroxisome proliferator-activated receptor (PPAR)-α gene in Dyslipidemia.. RMJ. 2020; 45(1): 54-57.


Web Style

Rashid A, Jafar S, Yaqub RK. Role of peroxisome proliferator-activated receptor (PPAR)-α gene in Dyslipidemia.. http://www.rmj.org.pk/?mno=40692 [Access: March 30, 2020].


AMA (American Medical Association) Style

Rashid A, Jafar S, Yaqub RK. Role of peroxisome proliferator-activated receptor (PPAR)-α gene in Dyslipidemia.. RMJ. 2020; 45(1): 54-57.



Vancouver/ICMJE Style

Rashid A, Jafar S, Yaqub RK. Role of peroxisome proliferator-activated receptor (PPAR)-α gene in Dyslipidemia.. RMJ. (2020), [cited March 30, 2020]; 45(1): 54-57.



Harvard Style

Rashid, A., Jafar, . S. & Yaqub, . R. K. (2020) Role of peroxisome proliferator-activated receptor (PPAR)-α gene in Dyslipidemia.. RMJ, 45 (1), 54-57.



Turabian Style

Rashid, Amir, Sadaf Jafar, and Raja Khalid Yaqub. 2020. Role of peroxisome proliferator-activated receptor (PPAR)-α gene in Dyslipidemia.. Rawal Medical Journal, 45 (1), 54-57.



Chicago Style

Rashid, Amir, Sadaf Jafar, and Raja Khalid Yaqub. "Role of peroxisome proliferator-activated receptor (PPAR)-α gene in Dyslipidemia.." Rawal Medical Journal 45 (2020), 54-57.



MLA (The Modern Language Association) Style

Rashid, Amir, Sadaf Jafar, and Raja Khalid Yaqub. "Role of peroxisome proliferator-activated receptor (PPAR)-α gene in Dyslipidemia.." Rawal Medical Journal 45.1 (2020), 54-57. Print.



APA (American Psychological Association) Style

Rashid, A., Jafar, . S. & Yaqub, . R. K. (2020) Role of peroxisome proliferator-activated receptor (PPAR)-α gene in Dyslipidemia.. Rawal Medical Journal, 45 (1), 54-57.








AUTHOR LOGIN

REVIEWER LOGIN

Indexed
&
Abstracted


Indexed in WHO Index Medicus IMEMR, Emromedex, Pakmedinet, ExtraMED and Scopus

  Approved by the Higher Education Commission of Pakistan and Pakistan Medical and Dental Council


ABOUT JOURNAL
POLICIES
STATEMENTS

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.

The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.